Publicaciones en las que colabora con Antonio García García (30)

2020

  1. The adrenal medulla modulates mechanical allodynia in a rat model of neuropathic pain

    International Journal of Molecular Sciences, Vol. 21, Núm. 21, pp. 1-16

2013

  1. Novel multitarget ligand ITH33/IQM9.21 provides neuroprotection in in vitro and in vivo models related to brain ischemia

    Neuropharmacology, Vol. 67, pp. 403-411

2012

  1. Galantamine elicits neuroprotection by inhibiting iNOS, NADPH oxidase and ROS in hippocampal slices stressed with anoxia/reoxygenation

    Neuropharmacology, Vol. 62, Núm. 2, pp. 1082-1090

2011

  1. N-Acylaminophenothiazines: Neuroprotective agents displaying multifunctional activities for a potential treatment of Alzheimer's disease

    European Journal of Medicinal Chemistry, Vol. 46, Núm. 6, pp. 2224-2235

2010

  1. Multipotent drugs with cholinergic and neuroprotective properties for the treatment of Alzheimer and neuronal vascular diseases. I. Synthesis, biological assessment, and molecular modeling of simple and readily available 2-aminopyridine-, and 2-chloropyridine-3,5-dicarbonitriles

    Bioorganic and Medicinal Chemistry, Vol. 18, Núm. 16, pp. 5861-5872

  2. Poststress treatment with PNU282987 can rescue SH-SY5Y cells undergoing apoptosis via α7 nicotinic receptors linked to a Jak2/Akt/HO-1 signaling pathway

    Free Radical Biology and Medicine, Vol. 49, Núm. 11, pp. 1815-1821

  3. Synergistic neuroprotective effect of combined low concentrations of galantamine and melatonin against oxidative stress in SH-SY5Y neuroblastoma cells

    Journal of Pineal Research, Vol. 49, Núm. 2, pp. 141-148

  4. Synthesis, inhibitory activity of cholinesterases, and neuroprotective profile of novel 1,8-naphthyridine derivatives

    Journal of Medicinal Chemistry, Vol. 53, Núm. 14, pp. 5129-5143

1996

  1. Blocking effects of otilonium on Ca2+ channels and secretion in rat chromaffin cells

    European Journal of Pharmacology, Vol. 298, Núm. 2, pp. 199-205

  2. Otilonium: A potent blocker of neuronal nicotinic ACh receptors in bovine chromaffin cells

    British Journal of Pharmacology, Vol. 117, Núm. 3, pp. 463-470

  3. The mechanism of calcium channel facilitation in bovine chromaffin cells

    Journal of Physiology, Vol. 494, Núm. 3, pp. 687-695

1995

  1. Veratridine‐induced oscillations of cytosolic calcium and membrane potential in bovine chromaffin cells.

    The Journal of Physiology, Vol. 482, Núm. 1, pp. 15-27

1994

  1. Modulation by L-type Ca 2+ channels and apamin-sensitive K + channels of muscarinic responses in cat chromaffin cells

    American Journal of Physiology - Cell Physiology, Vol. 266, Núm. 5 35-5

  2. Effects of Ca2+ channel antagonists on chromaffin cell death and cytosolic Ca2+ oscillations induced by veratridine

    European Journal of Pharmacology: Environmental Toxicology and, Vol. 270, Núm. 4, pp. 331-339

  3. Interactions between Ca2+, PCA50941 and Bay K 8644 in bovine chromaffin cells

    European Journal of Pharmacology: Molecular Pharmacology, Vol. 268, Núm. 3, pp. 293-303

  4. Localized L-type calcium channels control exocytosis in cat chromaffin cells

    Pflügers Archiv European Journal of Physiology, Vol. 427, Núm. 3-4, pp. 348-354

  5. Permeation by zinc of bovine chromaffin cell calcium channels: relevance to secretion

    Pflügers Archiv European Journal of Physiology, Vol. 429, Núm. 2, pp. 231-239

1993

  1. Activation of adrenal medullary L-arginine: nitric oxide pathway by stimuli which induce the release of catecholamines

    European Journal of Pharmacology: Molecular Pharmacology, Vol. 246, Núm. 3, pp. 213-218

  2. Separation between cytosolic calcium and secretion in chromaffin cells superfused with calcium ramps

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 90, Núm. 8, pp. 3284-3288

  3. Small-conductance Ca2+-activated K+ channels in bovine chromaffin cells

    Pflügers Archiv European Journal of Physiology, Vol. 423, Núm. 1-2, pp. 97-103